Riskpilot← Back to searchSign inGet full accessHospira Nordic AB
ABDissolvedOrg 5566279583Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20020 employees
Revenue 2019
SEK 0
EBITDA margin
—
-41% vs 2018
Equity ratio
100.0%
Financial strength
Net profit 2019
SEK -1,1M
-212% vs 2018
| Revenue | SEK 0 | — |
| EBITDA | SEK 71K | -41% |
| Net profit | SEK -1,1M | -212% |
| Total assets | SEK 7,8M | -15% |
| Equity | SEK 7,8M | -13% |
| Employees | 0 | — |
Legal name
Hospira Nordic AB
Org number
5566279583
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28 maj 2002
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-11-30
Financial year
January – December
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva import, marknadsföring, försäljning, distribution och kliniska prövningar av läkemedel i de Nordiska länderna samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | — | 322 984 | 3 275 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 5 658 | 129 558 | 488 | 120 | 71 |
| Depreciation & amort. | −80 | −57 | — | — | — |
| EBIT | 5 578 | 129 501 | 488 | 120 | 71 |
| Net financials | 283 | 124 | −233 | −491 | −46 |
| Profit before tax | 5 861 | 129 625 | 254 | −371 | 25 |
| Tax | −1 439 | −28 376 | −1 613 | 1 375 | −1 146 |
| Net profit | 4 422 | 101 249 | −1 359 | 1 004 | −1 121 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 159 822 | 309 231 | 209 062 | 9 164 | 7 775 |
| Equity | 84 002 | 185 251 | 183 892 | 8 896 | 7 775 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 75 820 | 123 980 | 25 170 | 268 | 0 |
| Total debt | 75 820 | 123 980 | 25 170 | 268 | — |
EBITDA margin
7100000.0%
This company
15.8%
Market median
+44936609% vs market
20152019
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152019
Return on equity
-14.4%
This company
18.4%
Market median
-178% vs market
20152019
Net profit margin
-112100000.0%
This company
8.1%
Market median
-1383950717% vs market
20152019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152019
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-12-01 – 2017-11-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-12-01 – 2016-11-30
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hospira Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Kristina Parkler | Chairman | 0 companies |
| Katri Suvi Tuuli Svennas | Board of Directors | 0 companies |
| Christoph Martin Hermann Varenhorst | Board of Directors | 0 companies |
| Tobias Jarmer | Board of Directors | 0 companies |
| Thomas Sigvard Bye | Board of Directors | 0 companies |